Listed

AMN Healthcare Services Inc: Form 10-Q for the period ended Sep 30, 2017

Filed with the SEC on Nov 3, 2017 and accepted by EDGAR at Nov 3, 2017, 13:57 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2017-07-01 to 2017-09-30$334.9mus-gaap:CostOfRevenue
Cost of revenue9 months2017-01-01 to 2017-09-30$997.1mus-gaap:CostOfRevenue
Gross profit3 months2017-07-01 to 2017-09-30$159.5mus-gaap:GrossProfit
Gross profit9 months2017-01-01 to 2017-09-30$482.3mus-gaap:GrossProfit
Selling, general and administrative3 months2017-07-01 to 2017-09-30$100.6mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2017-01-01 to 2017-09-30$299.3mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-07-01 to 2017-09-30$50.8mus-gaap:OperatingIncomeLoss
Operating income9 months2017-01-01 to 2017-09-30$159.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-07-01 to 2017-09-30$4.8mus-gaap:InterestExpense
Interest expense9 months2017-01-01 to 2017-09-30$14.9mus-gaap:InterestExpense
Income tax3 months2017-07-01 to 2017-09-30$17.9mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2017-01-01 to 2017-09-30$53.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-07-01 to 2017-09-30$28.1mus-gaap:NetIncomeLoss
Net income9 months2017-01-01 to 2017-09-30$91.4mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-07-01 to 2017-09-30$0.57us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2017-01-01 to 2017-09-30$1.85us-gaap:EarningsPerShareDiluted
Basic EPS3 months2017-07-01 to 2017-09-30$0.59us-gaap:EarningsPerShareBasic
Basic EPS9 months2017-01-01 to 2017-09-30$1.91us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2017-07-01 to 2017-09-3049,445,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2017-01-01 to 2017-09-3049,480,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2017-01-01 to 2017-09-30$96.4mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2017-01-01 to 2017-09-30$17.2mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases9 months2017-01-01 to 2017-09-30$7.1mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2017-09-30$19.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-09-30$442.5mus-gaap:AssetsCurrent
Total assetsAt period end2017-09-30$1.19bnus-gaap:Assets
Current liabilitiesAt period end2017-09-30$245.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-09-30$659.2mus-gaap:Liabilities
Shareholders' equityAt period end2017-09-30$532.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001142750-17-000013. Last ingested by Listed: Nov 5, 2026, 17:59 ET. Listed shows no prices and gives no investment advice.